Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

400 ARTÍCULOS , VIENDO DEL 181 AL 195

Effectiveness of autogenic training in improving motor performances in Parkinson's disease

Ajimsha MS, Majeed NA, Chinnavan E, Thulasyammal RP.

Complement Ther Med. 2014 Jun;22(3):419-25. doi: 10.1016/j.ctim.2014.03.013. Epub 2014 May 2.

Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson's disease (PD COMM pilot): study protocol for a randomized controlled trial

Sackley CM, Smith CH, Rick C, Brady MC, Ives N, Patel R, Roberts H, Dowling F, Jowett S, Wheatley K, Patel S, Kelly D, Sands G, Clarke C.

Trials. 2014 Jun 7;15:213. doi: 10.1186/1745-6215-15-213.

Missense dopamine transporter mutations associate with adult parkinsonism and ADHD

Hansen FH, Skjørringe T, Yasmeen S, Arends NV, Sahai MA, Erreger K, Andreassen TF, Holy M, Hamilton PJ, Neergheen V, Karlsborg M, Newman AH, Pope S, Heales SJ, Friberg L, Law I, Pinborg LH, Sitte HH, Loland C, Shi L, Weinstein H, Galli A, Hjermind LE, Møller LB, Gether U.

J Clin Invest. 2014 Jul;124(7):3107-20. doi: 10.1172/JCI73778. Epub 2014 Jun 9.

Glucocerebrosidase deficits in sporadic Parkinson disease

Murphy KE, Halliday GM.

Autophagy. 2014 Jul;10(7):1350-1. doi: 10.4161/auto.29074. Epub 2014 May 15.

Creatine for Parkinson's disease

Xiao Y, Luo M, Luo H, Wang J.

Cochrane Database Syst Rev. 2014 Jun 17;2014(6):CD009646. doi: 10.1002/14651858.CD009646.pub2.

Clinical characteristics of Parkinson's disease patients in Greece: a multicenter, nation-wide, cross-sectional study

Konitsiotis S, Bostantjopoulou S, Chondrogiorgi M, Katsarou Z, Tagaris G, Mavromatis I, Ntzani EE, Mentenopoulos G; members of the Greek Parkinson Study Group.

J Neurol Sci. 2014 Aug 15;343(1-2):36-40. doi: 10.1016/j.jns.2014.05.003. Epub 2014 May 11.

Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias

Rascol O, Fox S, Gasparini F, Kenney C, Di Paolo T, Gomez-Mancilla B.

Parkinsonism Relat Disord. 2014 Sep;20(9):947-56. doi: 10.1016/j.parkreldis.2014.05.003. Epub 2014 May 14.

Deep brain stimulation in psychiatry

Jesić MP, Zivanović' O, Nikolić I, Radovanović S, Sakić B, Jesić A.

Med Pregl. 2014 Jan-Feb;67(1-2):28-32.

Development and validation of a new screening questionnaire for dysphagia in early stages of Parkinson's disease

Simons JA, Fietzek UM, Waldmann A, Warnecke T, Schuster T, Ceballos-Baumann AO.

Parkinsonism Relat Disord. 2014 Sep;20(9):992-8. doi: 10.1016/j.parkreldis.2014.06.008. Epub 2014 Jun 26.

Genetics and genomics of Parkinson's disease

Lin MK, Farrer MJ.

Genome Med. 2014 Jun 30;6(6):48. doi: 10.1186/gm566. eCollection 2014.

Ascorbate- and zinc-responsive parkinsonism

Quiroga MJ, Carroll DW, Brown TM.

Ann Pharmacother. 2014 Nov;48(11):1515-20. doi: 10.1177/1060028014545356. Epub 2014 Jul 28.

Which patients with Parkinson's disease participate in clinical trials? One centre's experiences with a new cell based therapy trial (TRANSEURO)

Moore SF, Guzman NV, Mason SL, Williams-Gray CH, Barker RA.

J Parkinsons Dis. 2014;4(4):671-6. doi: 10.3233/JPD-140432.

Mode of action of adenosine A2A receptor antagonists as symptomatic treatment for Parkinson's disease

Mori A.

Int Rev Neurobiol. 2014;119:87-116. doi: 10.1016/B978-0-12-801022-8.00004-0.

Are the effects of community-based dance on Parkinson disease severity, balance, and functional mobility reduced with time? A 2-year prospective pilot study

Duncan RP, Earhart GM.

J Altern Complement Med. 2014 Oct;20(10):757-63. doi: 10.1089/acm.2012.0774. Epub 2014 Sep 5.

Anesthetic challenges for deep brain stimulation: a systematic approach

Chakrabarti R, Ghazanwy M, Tewari A.

N Am J Med Sci. 2014 Aug;6(8):359-69. doi: 10.4103/1947-2714.139281.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias